Global Genetic Disease Diagnostic Competitive Landscape Professional Research Report 2025
Research Summary
Genetic disease diagnostics involve the use of various laboratory techniques and tests to identify and analyze genetic factors associated with inherited disorders. These diagnostic methods aim to detect genetic mutations, variations, or abnormalities that may contribute to the development or risk of genetic diseases. Molecular genetic testing, chromosomal analysis, and DNA sequencing are common approaches used in genetic disease diagnostics. These tests provide valuable information about an individual＇s genetic makeup, helping healthcare professionals make accurate diagnoses, assess the risk of disease development, and guide treatment decisions. Genetic disease diagnostics are particularly crucial in identifying hereditary conditions, such as cystic fibrosis, Huntington＇s disease, and certain types of cancer with a strong genetic component. The results of genetic testing can also have implications for family members, allowing for informed decision-making and proactive healthcare management in individuals with a genetic predisposition to specific disorders.
According to DIResearch's in-depth investigation and research, the global Genetic Disease Diagnostic market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Genetic Disease Diagnostic include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Illumina, Da An Gene., CapitalBio Technology etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Genetic Disease Diagnostic. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Genetic Disease Diagnostic market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Genetic Disease Diagnostic market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Genetic Disease Diagnostic industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Genetic Disease Diagnostic Include:
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Illumina
Da An Gene.
CapitalBio Technology
Genetic Disease Diagnostic Product Segment Include:
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Genetic Disease Diagnostic Product Application Include:
Hospital
Medical Laboratory
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Genetic Disease Diagnostic Industry PESTEL Analysis
Chapter 3: Global Genetic Disease Diagnostic Industry Porter’s Five Forces Analysis
Chapter 4: Global Genetic Disease Diagnostic Major Regional Market Size and Forecast Analysis
Chapter 5: Global Genetic Disease Diagnostic Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Genetic Disease Diagnostic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Genetic Disease Diagnostic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Genetic Disease Diagnostic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Genetic Disease Diagnostic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Genetic Disease Diagnostic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Genetic Disease Diagnostic Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Genetic Disease Diagnostic Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Genetic Disease Diagnostic Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Genetic Disease Diagnostic Product by Type
- 1.2.1 Prenatal Diagnosis
- 1.2.2 Screening for Single Gene Genetic Disease
- 1.2.3 Preimplantation Genetic Testing
- 1.2.4 Others
- 1.3 Genetic Disease Diagnostic Product by Application
- 1.3.1 Hospital
- 1.3.2 Medical Laboratory
- 1.3.3 Others
- 1.4 Global Genetic Disease Diagnostic Market Size Analysis (2020-2032)
- 1.5 Genetic Disease Diagnostic Market Development Status and Trends
- 1.5.1 Genetic Disease Diagnostic Industry Development Status Analysis
- 1.5.2 Genetic Disease Diagnostic Industry Development Trends Analysis
- 2 Genetic Disease Diagnostic Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Genetic Disease Diagnostic Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Genetic Disease Diagnostic Market Analysis by Regions
- 4.1 Genetic Disease Diagnostic Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Genetic Disease Diagnostic Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Genetic Disease Diagnostic Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Genetic Disease Diagnostic Revenue Forecast by Region (2026-2032)
- 5 Global Genetic Disease Diagnostic Market Size by Type and Application
- 5.1 Global Genetic Disease Diagnostic Market Size by Type (2020-2032)
- 5.2 Global Genetic Disease Diagnostic Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Genetic Disease Diagnostic Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Genetic Disease Diagnostic Market Size by Type
- 6.4 North America Genetic Disease Diagnostic Market Size by Application
- 6.5 North America Genetic Disease Diagnostic Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Genetic Disease Diagnostic Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Genetic Disease Diagnostic Market Size by Type
- 7.4 Europe Genetic Disease Diagnostic Market Size by Application
- 7.5 Europe Genetic Disease Diagnostic Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Genetic Disease Diagnostic Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Genetic Disease Diagnostic Market Size by Type
- 8.4 China Genetic Disease Diagnostic Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Genetic Disease Diagnostic Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Genetic Disease Diagnostic Market Size by Type
- 9.4 APAC (excl. China) Genetic Disease Diagnostic Market Size by Application
- 9.5 APAC (excl. China) Genetic Disease Diagnostic Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Genetic Disease Diagnostic Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Genetic Disease Diagnostic Market Size by Type
- 10.4 Latin America Genetic Disease Diagnostic Market Size by Application
- 10.5 Latin America Genetic Disease Diagnostic Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Genetic Disease Diagnostic Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Type
- 11.4 Middle East & Africa Genetic Disease Diagnostic Market Size by Application
- 11.5 Middle East & Africa Genetic Disease Diagnostic Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Genetic Disease Diagnostic Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Genetic Disease Diagnostic Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Genetic Disease Diagnostic Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Abbott
- 13.1.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Abbott Genetic Disease Diagnostic Product Portfolio
- 13.1.3 Abbott Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 PerkinElmer
- 13.2.1 PerkinElmer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 PerkinElmer Genetic Disease Diagnostic Product Portfolio
- 13.2.3 PerkinElmer Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Roche Diagnostics
- 13.3.1 Roche Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Roche Diagnostics Genetic Disease Diagnostic Product Portfolio
- 13.3.3 Roche Diagnostics Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Bio Rad
- 13.4.1 Bio Rad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Bio Rad Genetic Disease Diagnostic Product Portfolio
- 13.4.3 Bio Rad Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Thermo Fisher Scientific
- 13.5.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Thermo Fisher Scientific Genetic Disease Diagnostic Product Portfolio
- 13.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 BGI Group
- 13.6.1 BGI Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 BGI Group Genetic Disease Diagnostic Product Portfolio
- 13.6.3 BGI Group Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Berry Genomics
- 13.7.1 Berry Genomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Berry Genomics Genetic Disease Diagnostic Product Portfolio
- 13.7.3 Berry Genomics Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Illumina
- 13.8.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Illumina Genetic Disease Diagnostic Product Portfolio
- 13.8.3 Illumina Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Da An Gene.
- 13.9.1 Da An Gene. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Da An Gene. Genetic Disease Diagnostic Product Portfolio
- 13.9.3 Da An Gene. Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 CapitalBio Technology
- 13.10.1 CapitalBio Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 CapitalBio Technology Genetic Disease Diagnostic Product Portfolio
- 13.10.3 CapitalBio Technology Genetic Disease Diagnostic Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Genetic Disease Diagnostic Industry Chain Analysis
- 14.2 Genetic Disease Diagnostic Industry Raw Material and Suppliers Analysis
- 14.2.1 Genetic Disease Diagnostic Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Genetic Disease Diagnostic Typical Downstream Customers
- 14.4 Genetic Disease Diagnostic Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Loading...
In this report,
We were unable to search inside this report.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook